Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 48433-016

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 48433-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 25 mg/100 mg Unit Carton Label (Image 01)

Carbidopa And Levodopa Extended-release Tablets, Usp 25 mg/100 mg Unit Carton Label (Image 01)
Label for Carbidopa and Levodopa extended-release tablets, USP, with a strength of 25 mg / 100 mg. The label shows two representations of the tablet, one with imprint "S 83." The product is supplied by Safecor Health, LLC, containing 100 tablets (10 x 10) and is for oral use. Prescription only.*
FDA Label Image

Carbidopa Structural Formula (Image 02)

Carbidopa Structural Formula (Image 02)
Chemical structure of carbidopa monohydrate, showing its molecular configuration including hydroxyl groups, amine, and carboxyl groups with an associated water molecule (H2O).*
FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 50 mg/200 mg Unit Carton Label (Image 03)

Carbidopa And Levodopa Extended-release Tablets, Usp 50 mg/200 mg Unit Carton Label (Image 03)
Carbidopa and Levodopa Extended-Release Tablets, USP 50 mg / 200 mg oral tablets in a package of 100 tablets (10 x 10) by Safecor Health, LLC. The label shows the NDC 48433-016-20 and includes an image of a gray elliptical tablet marked with '9 4'.*
FDA Label Image

Levodopa Structural Formula (Image 04)

Levodopa Structural Formula (Image 04)
Chemical structure of carbidopa, one of the active ingredients in Carbidopa and Levodopa tablets. The diagram shows the molecular arrangement including hydroxyl groups, an amino group, and a carboxylic acid moiety characteristic of carbidopa.*
FDA Label Image

Unit Carton (Image 05)

Unit Carton (Image 05)
Packaging label for UDL, a Safecor Health Company. The label includes safety warnings such as 'not child resistant,' 'for institutional use only,' and advice to keep drugs out of children's reach. It states the container provides light-resistance and notes a window for lot number and expiration date. Distributed by Safecor Health LLC in Rockford, Illinois, with a contact phone number and website.*
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)
Blue packaging label for Carbidopa and Levodopa extended-release tablets by Safecor Health, LLC. The label features the UDL logo with the tagline 'A Safecor Health Company,' storage instructions emphasizing light-resistance, and a note that the unit dose package is not child-resistant. Contact information including a phone number and website is also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.